Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
MERCURYLAB Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Negative
Low but stable ROE
Low but stable operating margin
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00754874.
Snapshot
See detailed analysis
MERCURYLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
MERCURYLAB Bulk, Block & Insider Trades
MERCURYLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its... Read More
Key personnel
Sanjay PatelD
Non-Executive Independent Chairman of the Board
Ms. Enu Khandelwal
Chief Financial Officer
Mr. Saurabh Mittal
Chief Operating Officer
Mr. Krishna Shah
Compliance Officer, Company Secretary
Mr. Rajendra R. ShahD
Managing Director, Director
Mr. Paresh J. MistryD
Non-Executive Non-Independent Director
Mr. Dilip R. ShahD
Non-Executive Non Independent Director
Ms. Janki R. ShahD
Non-Executive Non- Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Mercury Laboratories Ltd.?
The current share price of Mercury Laboratories Ltd. is ₹ 844.25 as of 09 Jan 2026.
What is the PE ratio of Mercury Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Mercury Laboratories Ltd. is 20.62 as of the latest financial data.
What is the ROE and ROCE of Mercury Laboratories Ltd.?
Mercury Laboratories Ltd. has a Return on Equity (ROE) of 9.15% and a Return on Capital Employed (ROCE) of 9.17% as per the latest financial reports.
What is the market cap of Mercury Laboratories Ltd.?
The market capitalization of Mercury Laboratories Ltd. stands at ₹ 101.31 Cr.
What is the dividend yield of Mercury Laboratories Ltd.?
The dividend yield of Mercury Laboratories Ltd. is 0.41% based on the current market price.
What is the RSI of Mercury Laboratories Ltd.?
The Relative Strength Index (RSI) of Mercury Laboratories Ltd. is 53.08.
What is the FII and DII holding in Mercury Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Mercury Laboratories Ltd. shares.
What sector does Mercury Laboratories Ltd. belong to?
Mercury Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Mercury Laboratories Ltd. stock?
The beta of Mercury Laboratories Ltd. stock is 0.49, indicating its volatility relative to the broader market.
